Literature DB >> 32107563

The risk factors of new-onset atrial fibrillation after pacemaker implantation.

Zhaodi Wu1, Xueying Chen2, Junbo Ge2, Yangang Su3.   

Abstract

OBJECTIVE: The aim of this study was to determine the incidence of newly detected atrial fibrillation (AF) in patients following dual-chamber pacemaker (PPM) implantation and to define the clinical predictors of new-onset AF in a Chinese cohort.
METHODS: A total of 219 patients without documented AF that underwent dual-chamber PPM implantation for sick sinus syndrome (SSS) (n = 88) or atrioventricular block (AVB) (n = 131) were prospectively studied. All patients were invited to follow-up at 1 month, 3 months and 6 months after the pacemaker implantation procedure, and once every 6 months thereafter. An atrial high-rate episode (AHRE) ≥5 min and an atrial rate ≥180 bpm was defined as AF.
RESULTS: During follow-up of 884 ± 180 days, AF was detected in 56 (26%) patients. Using Kaplan-Meier survival curves with Log-rank test, SSS patients with a cumulative percentage of ventricular pacing (Cum % VP) ≥60% had a significantly higher rate of new-onset AF compared to AVB patients (p = 0.026) and SSS patients with Cum % VP <60% (p = 0.018). On multivariate Cox regression analysis, higher Cum % VP independently predicted higher morbidity of newly detected AF (hazard ratio [HR] 1.01; confidence interval [CI] 1.00 ~ 1.02; p = 0.035) among SSS patients. Larger left atrial (LA) dimension was a predictor of newly detected AF (HR 1.06; CI 1.01 ~ 1.14; p = 0.046) in AVB patients.
CONCLUSION: The incidence of AF following dual-chamber PPM implantation was relatively high in this Chinese cohort. High Cum % VP and larger LA dimension could independently predict new-onset AF after dual-chamber PPM implantation in SSS and AVB patients, respectively.

Entities:  

Keywords:  Atrioventricular block; Cumulative percentage of ventricular pacing; Dual chamber pacemaker; Left atrial dimension; Sick sinus syndrome

Mesh:

Year:  2020        PMID: 32107563     DOI: 10.1007/s00059-019-04869-z

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  7 in total

Review 1.  Asymptomatic atrial fibrillation on device interrogation.

Authors:  Hoong Sern Lim; Gregory Y H Lip
Journal:  J Cardiovasc Electrophysiol       Date:  2008-05-09

2.  Newly detected atrial fibrillation following dual chamber pacemaker implantation.

Authors:  Jim W Cheung; Richard J Keating; Kenneth M Stein; Steven M Markowitz; Sei Iwai; Bindi K Shah; Bruce B Lerman; Suneet Mittal
Journal:  J Cardiovasc Electrophysiol       Date:  2006-11-01

3.  Frequency, duration, and predictors of newly-diagnosed atrial fibrillation following dual-chamber pacemaker implantation in patients without a previous history of atrial fibrillation.

Authors:  Suneet Mittal; Kenneth Stein; F Roosevelt Gilliam; Stacia Merkel Kraus; Timothy Edward Meyer; Shelly Ann Christman
Journal:  Am J Cardiol       Date:  2008-06-12       Impact factor: 2.778

4.  Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese.

Authors:  Kuo-Liong Chien; Ta-Chen Su; Hsiu-Ching Hsu; Wei-Tien Chang; Pei-Chung Chen; Ming-Fong Chen; Yuan-Teh Lee
Journal:  Int J Cardiol       Date:  2008-11-30       Impact factor: 4.164

5.  Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices).

Authors:  Giuseppe Boriani; Taya V Glotzer; Massimo Santini; Teena M West; Mirko De Melis; Milan Sepsi; Maurizio Gasparini; Thorsten Lewalter; John A Camm; Daniel E Singer
Journal:  Eur Heart J       Date:  2013-12-11       Impact factor: 29.983

6.  Long-term clinical effects of ventricular pacing reduction with a changeover mode to minimize ventricular pacing in a general pacemaker population.

Authors:  Martin Stockburger; Serge Boveda; Javier Moreno; Antoine Da Costa; Robert Hatala; Johannes Brachmann; Christian Butter; Javier Garcia Seara; Mara Rolando; Pascal Defaye
Journal:  Eur Heart J       Date:  2014-09-01       Impact factor: 29.983

7.  Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial.

Authors:  Giuseppe Boriani; Raymond Tukkie; Antonis S Manolis; Lluis Mont; Helmut Pürerfellner; Massimo Santini; Giuseppe Inama; Paolo Serra; João de Sousa; Giovanni Luca Botto; Lorenza Mangoni; Andrea Grammatico; Luigi Padeletti
Journal:  Eur Heart J       Date:  2014-04-25       Impact factor: 29.983

  7 in total
  2 in total

1.  Cardiac variables associated with atrial fibrillation occurrence and mortality in octogenarians implanted with dual chamber permanent pacemakers.

Authors:  Mert İlker Hayıroğlu; Tufan Çınar; Göksel Çinier; Gizem Yüksel; Levent Pay; Kıvanç Keskin; Cahit Coşkun; Gökçem Ayan; Vedat Çiçek; Ahmet İlker Tekkeşin
Journal:  Aging Clin Exp Res       Date:  2022-07-14       Impact factor: 4.481

2.  Epidemiology of Atrial Fibrillation and Related Myocardial Ischemia or Arrhythmia Events in Chinese Community Population in 2019.

Authors:  Cheng Li; Haicheng Wang; Mohan Li; Xiangjun Qiu; Qunshan Wang; Jian Sun; Mei Yang; Xiangfei Feng; Shu Meng; Pengpai Zhang; Bo Liu; Wei Li; Mu Chen; Yan Zhao; Rui Zhang; Binfeng Mo; Yuling Zhu; Baohong Zhou; Min Chen; Xia Liu; Yuelin Zhao; Mingzhen Shen; Jinkang Huang; Li Luo; Hong Wu; Yi-Gang Li
Journal:  Front Cardiovasc Med       Date:  2022-04-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.